SCHOTT Pharma
Alejandro Rueda is a seasoned professional in project and initiative management, currently serving as a Global Project Manager at SCHOTT Pharma, focusing on drug containment solutions since November 2023. Prior experience includes leading global initiatives at Wella Company and managing innovation portfolios for Procter & Gamble across various roles, including Initiative Management Director and Engineering Project Manager. Alejandro has a comprehensive background in supply chain optimization and manufacturing management, with earlier roles at Venproma overseeing operations in disposable wood product lines. Alejandro's educational credentials include a Diploma in Digital Excellence from IMD, a Master of Science in Manufacturing Systems Engineering from Lehigh University, and a Bachelor of Science in Mechanical Engineering from the University of Pennsylvania.
This person is not in any teams
This person is not in any offices
SCHOTT Pharma
1 followers
SCHOTT Pharma designs solutions grounded in science to ensure that medications are safe and easy to use for people around the world – because human health matters. Every day, more than 4,700 people from 65 nations work at SCHOTT Pharma to contribute to global healthcare. The company has 17 manufacturing sites across major pharmaceutical hubs in Europe, the Americas and Asia. SCHOTT Pharma maintains a diverse portfolio of injectable drug containment and delivery solutions. These solutions range from prefillable glass and polymer syringes, cartridges, vials and ampoules. The company has focused on developing innovations for future technologies by: • Creating over 1000 patents and technologies developed in-house • Building a state-of-the-art Research and Development Center in Switzerland • Absorbing over 130 professionals focused on Research and Development Despite being a pharmaceutical manufacturer, SCHOTT Pharma aims to become climate-neutral by 2030. The company commits to this through sustainable development approaches in the society and the environment. Based in Mainz, Germany, it is part of SCHOTT AG that falls under the Carl Zeiss Foundation. SCHOTT Pharma has over 1700 global customers, 30 of which are the leading pharmaceutical manufacturers of injectable drugs. These customers have generated combined sales of EUR 899 million in the fiscal year 2023. Contact us now: pharma@schott.com Data protection: https://www.schott-pharma.com/en/legal-social